Crop Life Science (NSE:CLSL) Total Equity: ₹880 Mil (As of Mar. 2026)


NSE:CLSL Crop Life Science Ltd NSE:CLSL
58 GF Score
Price ₹43.00
GF Value ₹54.88
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Crop Life Science Total Equity?

Crop Life Science NSE:CLSL 58 Total Equity is ₹880 Mil as of Mar. 2026. GuruFocus rates NSE:CLSL with a GF Score™ of 58/100 and a GF Value™ of ₹54.88 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Crop Life Science's total equity for the quarter that ended in Mar. 2026 was ₹880 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Crop Life Science Total Equity Historical Data

* Premium members only.

The historical data trend for Crop Life Science's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crop Life Science Total Equity Chart

Crop Life Science Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial 360.19 405.54 759.12 813.50 880.01

Crop Life Science Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 759.12 787.05 813.50 841.52 880.01
NSE:CLSL
58GF Score
Crop Life Science Ltd NSE:CLSL
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crop Life Science Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Crop Life Science's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=2079.529-1199.517
=880

Crop Life Science's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=2079.529-1199.517
=880

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹880 Mil mean?
Crop Life Science (NSE:CLSL) has a Total Equity of ₹880 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Crop Life Science and its competitors.
Is Crop Life Science's Total Equity too high?
Crop Life Science's current Total Equity is ₹880 Mil. Overall, Crop Life Science has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's Total Equity compare to CTVA and CF?
Crop Life Science's Total Equity of ₹880 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for an Agriculture company?
A good Total Equity depends on the Agriculture industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Crop Life Science and its competitors. Crop Life Science's current Total Equity is ₹880 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹54.88, compared to a current price of ₹43.00 — trading 21.6% below its estimated fair value. The current Total Equity is ₹880 Mil. Crop Life Science's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current Total Equity is ₹880 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Crop Life Science (NSE:CLSL) Overvalued in 2026?

Based on GuruFocus' analysis, Crop Life Science stock appears to be undervalued. The current stock price of ₹43.00 is trading 21.6% below its estimated GF Value™ of ₹54.88. GuruFocus considers Crop Life Science to be Modestly Undervalued.

Key valuation signals for NSE:CLSL:

  • Total Equity: ₹880 Mil
  • GF Value™: ₹54.88 vs. price of ₹43.00 (21.6% below fair value)
  • GF Score™: 58/100 with 8 warning signs

No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Crop Life Science Business Description

Address Old Padra Road, 6th Floor, ABS Tower, Near Chakli Circle, Vadodara, GJ, IND, 390007
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
58GF Score

Get the complete analysis for NSE:CLSL

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹43.00
Price
₹54.88
GF Value